Amarin Co. plc Sees Unusually High Options Volume (AMRN)
Amarin Co. plc (NASDAQ:AMRN) was the recipient of unusually large options trading activity on Monday. Stock investors acquired 16,439 put options on the company, AnalystRatingsNetwork reports. This represents an increase of approximately 135% compared to the typical volume of 6,999 put options.
A number of analysts have recently weighed in on AMRN shares. Analysts at Oppenheimer cut their price target on shares of Amarin Co. plc from $7.00 to $6.00 in a research note to investors on Monday. They now have a “market perform” rating on the stock. Separately, analysts at Aegis reiterated a “buy” rating on shares of Amarin Co. plc in a research note to investors on Monday. They now have a $30.00 price target on the stock. Finally, analysts at Leerink Swann reiterated an “outperform” rating on shares of Amarin Co. plc in a research note to investors on Monday. Three research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $12.05.
Amarin Co. plc (NASDAQ:AMRN) opened at 5.01 on Tuesday. Amarin Co. plc has a 52-week low of $4.50 and a 52-week high of $12.96. The stock has a 50-day moving average of $6.54 and a 200-day moving average of $6.43. The company’s market cap is $864.8 million.
Amarin Co. plc (NASDAQ:AMRN) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.38) by $0.12. The company had revenue of $5.50 million for the quarter. On average, analysts predict that Amarin Co. plc will post $-1.37 earnings per share for the current fiscal year.
Amarin Corporation plc (NASDAQ:AMRN) is a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.